Viatris Inc recall records

12 reported ongoing

23 records in this archive. Latest source date Mar 17, 2026.

FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

Records and reported status

FDA drug enforcement

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Class IIReported terminated

Distribution: USA nationwide.

Official source for Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Vi...
FDA drug enforcement

Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Class IIReported terminated

Distribution: USA nationwide.

Official source for Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by V...
FDA drug enforcement

Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only, Distributed by: Meda pharmaceuticals Inc. (...

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Class IIReported terminated

Distribution: Product was distributed to 10 distributors who may have further distribute the product to the retail level.

Official source for Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml...

Reasons in these listed records

  • Failed Dissolution Specifications
  • Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
  • Superpotent Drug and Subpotent Drug: potency failures obtained
  • Failed Impurities/Degradation Specifications

These examples come from this result page and are not a ranking of every recall reason.

Checking Viatris Inc

Is there a recall on viatris inc right now?

This archive contains 23 records, including 12 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.

How do I check my package or product?

Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.

Does a matching name mean every item is included?

A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.

What if the search finds no matching record?

This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.

Where can I find older records?

Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.

Keep checking